Quanta SC+ Efficacy and Safety

A human factors test of the Quanta SC+ of 60 patients in the UK (1,333 treatments) using conventional, thrice weekly schedules had no serious adverse events. Ultrafiltration was within acceptable limits.The threshold standardized Kt/V was exceeded in 94% of treatments, and in 97.6% of patients who did not have significantly residual kidney function.

Read the abstract » | (added 11-12-2020)